BioSpace News Archive

Innovative Partnership Will Raise Awareness for Colorectal Cancer Which Is The Third Most Commonly Diagnosed Cancer

Initiation of Phase 2B Study Follows Quickly After FDA Grants RMAT Designation for Knee OA.

Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers

PharmaCord LLC, a rapidly growing patient services company that provides customized solutions to the biopharmaceutical industry, has announced the appointment of Patrick Lee as vice president of strategy.

Collaboration plans to establish Biocept as Thermo Fisher Center of Excellence for liquid biopsy and to pursue commercial opportunities in both pharmaceutical and clinical markets.

Ms. Wilkinson was presented with the award after her keynote on “Digitising the National Health Service” at the 3rd U.K. CDO Summit in London, England, by CDO Club founder David Mathison.

Frances brings more than 30 years of pharmaceutical and regulatory experience, having previously worked for several global and emerging pharmaceutical companies.

The report displays the diverse initiatives and growth of companies across Canada; the potential talent to help grow the industry and the positive impact of BioTalent Canada’s many wage subsidy programs on the industry.

Proclara Biosciences, a clinical stage biotechnology company developing novel therapies for diseases caused by protein misfolding, today announced that preclinical data supporting the development of General Amyloid Interaction Motif (GAIM)-based therapies for the treatment of peripheral amyloidoses were presented at the 16th International Symposium on Amyloidosis (ISA) in Kumamoto, Japan.

bluebird and Celgene will share 50% of U.S. costs and profits